A lab-scale, tunable, single-filament, point-to-point nonthermal dielectric-barrier discharge (DBD) plasma device was built to study the mechanisms of inactivation of aerosolized bacterial pathogens. The system inactivates airborne antibiotic-resistant pathogens efficiently.
Our nonthermal plasma-based technology is not only inactivated airborne pathogens in seconds, but is tunable, cost-effective, and ideal for decontamination/disinfection of pathogens in air of risk units at healthcare centers.
The proposed technology could have high place in the inactivation of airborne COVID-19 coronavirus particles in intensive care units and other high-risk healthcare units. Dr. Suresh G Joshi, MD, PhD, MSc, FIDSA
PLoS ONE 12(2): e0171434. doi:10.1371/journal.pone.0171434